Document is current
Any future updates will be listed below
-
Authors
Hansen, Tine Willum https://orcid.org/0000-0003-2274-0352
Ripa, Rasmus S. https://orcid.org/0000-0003-2035-2321
- License Information
-
More Information
Article History
Received: 29 November 2024
Accepted: 13 February 2025
First Online: 6 March 2025
Declarations
:
: Tine W. Hansen and Rasmus S. Ripa hold shares in Novo Nordisk A/S. Rasmus S. Ripa has received consultancy fees from Novo Nordisk A/S and Minerva Imaging. Tine W. Hansen is an Editorial Board member of Diabetes Therapy. Tine W. Hansen was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This article is based on previously published studies and does not contain any new studies with human participants or animals performed by any of the authors.
